(Q50780745)

English

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.

scientific article published in January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

0 references

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

author name string

Muneki Hotomi

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Yorihiko Ikeda

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Masaki Suzumoto

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Kazuma Yamauchi

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Bruce A Green

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Gary Zlotnick

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Dewan S Billal

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Jun Shimada

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Keiji Fujihara

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Noboru Yamanaka

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

language of work or name

0 references

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

23

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

1294-1300

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Role of nontypeable Haemophilus influenzae in pediatric respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Nontypeable Haemophilus influenzae: challenges in developing a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

The microbiologic and immunologic basis for recurrent otitis media in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Mechanisms of recurrent otitis media: importance of the immune response to bacterial surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

NadN and e (P4) are essential for utilization of NAD and nicotinamide mononucleotide but not nicotinamide riboside in Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Purification and characterization of a recombinant Haemophilus influenzae outer membrane phosphomonoesterase e (P4).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Role of nasopharyngeal bacterial flora in the evaluation of recurrent middle ear infections in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

CD8+ T cells have an essential role in pulmonary clearance of nontypeable Haemophilus influenzae following mucosal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding between outer membrane proteins of nontypeable Haemophilus influenzae and human nasopharyngeal mucin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.08.042

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/15652672

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50780745&oldid=1799290830"